Serum Insulin, Insulin-Like Growth Factor-1, Testosterone and Lipid Profile Levels in Benign Prostatic Hyperplasia and Prostate Cancer at Diagnosis
Afreen Khan, Esha Sarkar, Anu Chandra, Syed Tasleem Raza, Abbas A Mahdi, S N Sankhwar, Preeti Agarwal, Avneet Gupta · 2024
Read Serum Insulin, Insulin-Like Growth Factor-1, Testosterone and Lipid Profile Levels in Benign Prostatic Hyperplasia and Prostate Cancer at Diagnosis by Afreen Khan, Esha Sarkar, Anu Chandra, Syed Tasleem Raza, Abbas A Mahdi, S N Sankhwar, Preeti Agarwal, Avneet Gupta (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11707001.txt.
Description
Afreen Khan and seven co-authors compared hormone and fat levels in prostate patients and healthy men, in a 2024 study. One hundred fifty men took part at diagnosis. Fifty had benign prostate enlargement, fifty had confirmed prostate cancer, and fifty were disease-free controls. Blood levels of insulin, a growth factor, testosterone, and fats were measured.
Insulin and the growth factor ran higher in both patient groups. Levels peaked in the cancer group. Higher values tracked with higher cancer grade scores. That link held across the grading scales used. Blood fats, by contrast, showed no clear tie to grade. The authors conclude insulin and the growth factor associate with disease presence and severity. Testosterone results are reported alongside. The findings may inform risk research on metabolic factors in prostate disease.
Catalog record
| CREATOR | Afreen Khan, Esha Sarkar, Anu Chandra, Syed Tasleem Raza, Abbas A Mahdi, S N Sankhwar, Preeti Agarwal, Avneet Gupta |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |